fda warning letter compounding semaglutide news The New York Times spotlighted MEDVi. The had already warned the self-proclaimed 'fastest growing company in history.' Out of Shortage, Into Controversy:

If your appetite is very low, read eating on GLP-1 with a tiny appetite

Delivered via nasal spray for fast absorption, it supports energy, brain clarity, and cellular repairmaking it a favorite among professionals, parents, and high-performers

This fragmentation makes it nearly impossible to construct a cross-tissue causal model when each domain interprets the data through its own methodological and conceptual lens

A study presented recently at ARVO 2026 analyzed the incidence of glaucoma, macular and ophthalmic diseases over a four-year period among non-diabetic adults prescribed GLP-1 drugs and found these medications provide a variety of protective signals

Objective This study aims to conduct a multifactor investigation of product quality and patient safety risks associated with the unregulated online sale of semaglutide by examining product availability and vendor characteristics and assessing product quality through test purchases

Both contain the same active ingredient and produce similar weight loss results